Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1681

1.

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.

Lokhorst HM, Plesner T, Laubach JP, Nahi H, Gimsing P, Hansson M, Minnema MC, Lassen U, Krejcik J, Palumbo A, van de Donk NW, Ahmadi T, Khan I, Uhlar CM, Wang J, Sasser AK, Losic N, Lisby S, Basse L, Brun N, Richardson PG.

N Engl J Med. 2015 Aug 26. [Epub ahead of print]

PMID:
26308596
2.

Hematopoietic cell transplantation in patients with medication-related osteonecrosis of the jaws.

Mawardi H, Glotzbecker B, Richardson P, Woo SB.

Biol Blood Marrow Transplant. 2015 Aug 21. pii: S1083-8791(15)00550-9. doi: 10.1016/j.bbmt.2015.08.021. [Epub ahead of print]

PMID:
26303103
3.

CXCR4 and Glioblastoma.

Richardson PJ.

Anticancer Agents Med Chem. 2015 Aug 24. [Epub ahead of print]

PMID:
26299663
4.

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma.

Prabhala RH, Fulciniti M, Pelluru D, Rashid N, Nigroiu A, Nanjappa P, Pai C, Lee S, Prabhala NS, Bandi RL, Smith R, Lazo-Kallanian SB, Valet S, Raje N, Gold JS, Richardson PG, Daley JF, Anderson KC, Ettenberg SA, Di Padova F, Munshi NC.

Leukemia. 2015 Aug 21. doi: 10.1038/leu.2015.228. [Epub ahead of print]

PMID:
26293646
5.

Guidelines for determination of the number of prior lines of therapy in multiple myeloma.

Rajkumar SV, Richardson P, San Miguel JF.

Blood. 2015 Aug 13;126(7):921-2. doi: 10.1182/blood-2015-05-647636. No abstract available.

PMID:
26272048
6.

Parental attitudes to clinical studies in healthy siblings.

Blair JC, Povall A, Richardson P, Peak M.

Arch Dis Child. 2015 Aug 11. pii: archdischild-2015-308938. doi: 10.1136/archdischild-2015-308938. [Epub ahead of print] No abstract available.

PMID:
26265288
7.

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L, Richardson P, Caltagirone S, Lahuerta JJ, Facon T, Bringhen S, Gay F, Attal M, Passera R, Spencer A, Offidani M, Kumar S, Musto P, Lonial S, Petrucci MT, Orlowski RZ, Zamagni E, Morgan G, Dimopoulos MA, Durie BG, Anderson KC, Sonneveld P, San Miguel J, Cavo M, Rajkumar SV, Moreau P.

J Clin Oncol. 2015 Aug 3. pii: JCO.2015.61.2267. [Epub ahead of print]

PMID:
26240224
8.

Hepatocellular Carcinoma in the Absence of Cirrhosis in US Veterans is Associated with Non-Alcoholic Fatty Liver Disease.

Mittal S, El-Serag HB, Sada YH, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA.

Clin Gastroenterol Hepatol. 2015 Jul 18. pii: S1542-3565(15)00978-7. doi: 10.1016/j.cgh.2015.07.019. [Epub ahead of print]

PMID:
26196445
9.

BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics.

Touzeau C, Ryan J, Guerriero J, Moreau P, Chonghaile TN, Le Gouill S, Richardson P, Anderson K, Amiot M, Letai A.

Leukemia. 2015 Jul 15. doi: 10.1038/leu.2015.184. [Epub ahead of print] No abstract available.

PMID:
26174630
10.

What Shape is Your Resident in? Using a Radar Plot to Guide a Milestone Clinical Competency Discussion.

Harrington DT, Miner TJ, Ng T, Charpentier KP, Richardson P, Cioffi WG.

J Surg Educ. 2015 Jul 1. pii: S1931-7204(15)00093-8. doi: 10.1016/j.jsurg.2015.04.005. [Epub ahead of print] Review.

PMID:
26143521
11.

Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia.

Ghobrial IM, Redd R, Armand P, Banwait R, Boswell E, Chuma S, Huynh D, Sacco A, Roccaro AM, Perilla-Glen A, Noonan K, MacNabb M, Leblebjian H, Warren D, Henrick P, Castillo JJ, Richardson PG, Matous J, Weller E, Treon SP.

Leukemia. 2015 Jul 3. doi: 10.1038/leu.2015.164. [Epub ahead of print]

PMID:
26139427
12.

Get the Basics on End-of-Life Medications.

Richardson P.

ONS Connect. 2015 Jun;30(2):45. No abstract available.

PMID:
26137829
13.

When "Do Everything" Becomes "Do No More".

Richardson P.

ONS Connect. 2015 Jun;30(2):28-32. No abstract available.

PMID:
26137825
14.

Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma.

Cottini F, Hideshima T, Suzuki R, Tai YT, Bianchini G, Richardson PG, Anderson KC, Tonon G.

Cancer Discov. 2015 Jun 16. [Epub ahead of print]

PMID:
26080835
15.

David Sackett and the birth of Evidence Based Medicine: How to Practice and Teach EBM.

Richardson PE.

BMJ. 2015 Jun 8;350:h3089. doi: 10.1136/bmj.h3089. No abstract available.

PMID:
26055193
16.

Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma.

Richardson PG, Laubach JP, Lonial S, Moreau P, Yoon SS, Hungria VT, Dimopoulos MA, Beksac M, Alsina M, San-Miguel JF.

Expert Rev Anticancer Ther. 2015 Jul;15(7):737-48. doi: 10.1586/14737140.2015.1047770. Epub 2015 Jun 7.

PMID:
26051506
17.

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.

Lonial S, Dimopoulos M, Palumbo A, White D, Grosicki S, Spicka I, Walter-Croneck A, Moreau P, Mateos MV, Magen H, Belch A, Reece D, Beksac M, Spencer A, Oakervee H, Orlowski RZ, Taniwaki M, Röllig C, Einsele H, Wu KL, Singhal A, San-Miguel J, Matsumoto M, Katz J, Bleickardt E, Poulart V, Anderson KC, Richardson P; ELOQUENT-2 Investigators.

N Engl J Med. 2015 Aug 13;373(7):621-31. doi: 10.1056/NEJMoa1505654. Epub 2015 Jun 2.

PMID:
26035255
18.

Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations.

Varga C, Xie W, Laubach J, Ghobrial IM, O'Donnell EK, Weinstock M, Paba-Prada C, Warren D, Maglio ME, Schlossman R, Munshi NC, Raje N, Weller E, Anderson KC, Mitsiades CS, Richardson PG.

Br J Haematol. 2015 Jun;169(6):843-50. doi: 10.1111/bjh.13382.

PMID:
26032514
19.

Promising therapies in multiple myeloma.

Bianchi G, Richardson PG, Anderson KC.

Blood. 2015 Jul 16;126(3):300-10. doi: 10.1182/blood-2015-03-575365. Epub 2015 Jun 1. No abstract available.

PMID:
26031917
20.

Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.

Görgün G, Samur MK, Cowens KB, Paula S, Bianchi G, Anderson JE, White RE, Singh A, Ohguchi H, Suzuki R, Kikuchi S, Harada T, Hideshima T, Tai YT, Laubach JP, Raje N, Magrangeas F, Minvielle S, Avet-Loiseau H, Munshi NC, Dorfman DM, Richardson PG, Anderson KC.

Clin Cancer Res. 2015 May 15. [Epub ahead of print]

PMID:
25979485
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk